Timothy L. Ratliff - Publications

Affiliations: 
University of Iowa, Iowa City, IA 
Area:
Microbiology Biology

207 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Orillion AR, Damayanti NP, Shen L, Adelaiye-Ogala R, Affronti HC, Elbanna M, Chintala S, Ciesielski MJ, Fontana L, Kao C, Elzey BD, Ratliff TL, Nelson DE, Smiraglia DJ, Abrams SI, et al. Dietary protein restriction reprograms tumor associated macrophages and enhances immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30190370 DOI: 10.1158/1078-0432.CCR-18-0980  0.32
2018 Lee HJ, Li J, Vickman RE, Li J, Liu R, Durkes A, Elzey BD, Yue S, Liu X, Ratliff TL, Cheng JX. Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway. Molecular Cancer Research : McR. PMID 29545473 DOI: 10.1158/1541-7786.MCR-17-0665  0.32
2016 Vickman RE, Crist SA, Kerian K, Eberlin L, Cooks RG, Burcham GN, Buhman KK, Hu CD, Mesecar AD, Cheng L, Ratliff TL. Cholesterol Sulfonation Enzyme, SULT2B1b, Modulates AR and Cell Growth Properties in Prostate Cancer. Molecular Cancer Research : McR. PMID 27341831 DOI: 10.1158/1541-7786.MCR-16-0137  0.32
2015 Cimen Bozkus C, Elzey BD, Crist SA, Ellies LG, Ratliff TL. Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity. Journal of Immunology (Baltimore, Md. : 1950). 195: 5237-50. PMID 26491198 DOI: 10.4049/jimmunol.1500959  0.32
2015 Wang HH, Wang L, Jerde TJ, Chan BD, Savran CA, Burcham GN, Crist S, Ratliff TL. Characterization of autoimmune inflammation induced prostate stem cell expansion. The Prostate. PMID 26174474 DOI: 10.1002/pros.23043  0.32
2015 Wang L, Zoetemelk M, Chitteti BR, Ratliff TL, Myers JD, Srour EF, Broxmeyer H, Jerde TJ. Expansion of prostate epithelial progenitor cells after inflammation of the mouse prostate. American Journal of Physiology. Renal Physiology. 308: F1421-30. PMID 25925259 DOI: 10.1152/ajprenal.00488.2014  0.32
2015 Lee SS, Li J, Tai JN, Ratliff TL, Park K, Cheng JX. Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment. Acs Nano. 9: 2420-32. PMID 25662106 DOI: 10.1021/nn504025a  0.32
2015 Hinotsu S, Kamatani N, Ratliff TL, Akaza H. A systematic review and meta-analysis on the safety and efficacy of different strains of Mycobacterium bovis bacillus Calmette-Guérin for non-muscle invasive bladder cancer in Japan and US European Journal of Oncology Pharmacy. 8: 8-18.  0.32
2014 Burcham GN, Cresswell GM, Snyder PW, Chen L, Liu X, Crist SA, Henry MD, Ratliff TL. Impact of prostate inflammation on lesion development in the POET3(+)Pten(+/-) mouse model of prostate carcinogenesis. The American Journal of Pathology. 184: 3176-91. PMID 25455686 DOI: 10.1016/j.ajpath.2014.08.021  0.32
2014 Yue S, Li J, Lee SY, Lee HJ, Shao T, Song B, Cheng L, Masterson TA, Liu X, Ratliff TL, Cheng JX. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metabolism. 19: 393-406. PMID 24606897 DOI: 10.1016/j.cmet.2014.01.019  0.32
2013 Crist SA, Elzey BD, Ahmann MT, Ratliff TL. Early growth response-1 (EGR-1) and nuclear factor of activated T cells (NFAT) cooperate to mediate CD40L expression in megakaryocytes and platelets. The Journal of Biological Chemistry. 288: 33985-96. PMID 24106272 DOI: 10.1074/jbc.M113.511881  0.32
2013 Song B, Liu XS, Rice SJ, Kuang S, Elzey BD, Konieczny SF, Ratliff TL, Hazbun T, Chiorean EG, Liu X. Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. Molecular Cancer Therapeutics. 12: 58-68. PMID 23188630 DOI: 10.1158/1535-7163.MCT-12-0632  0.32
2012 Chou CK, Schietinger A, Liggitt HD, Tan X, Funk S, Freeman GJ, Ratliff TL, Greenberg NM, Greenberg PD. Cell-intrinsic abrogation of TGF-β signaling delays but does not prevent dysfunction of self/tumor-specific CD8 T cells in a murine model of autochthonous prostate cancer. Journal of Immunology (Baltimore, Md. : 1950). 189: 3936-46. PMID 22984076 DOI: 10.4049/jimmunol.1201415  0.32
2012 Coon BG, Crist S, González-Bonet AM, Kim HK, Sowa J, Thompson DH, Ratliff TL, Aguilar RC. Fibronectin attachment protein from bacillus Calmette-Guerin as targeting agent for bladder tumor cells. International Journal of Cancer. Journal International Du Cancer. 131: 591-600. PMID 21901746 DOI: 10.1002/ijc.26413  0.32
2011 Deng X, Elzey BD, Poulson JM, Morrison WB, Ko SC, Hahn NM, Ratliff TL, Hu CD. Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patients. American Journal of Cancer Research. 1: 834-44. PMID 22016831  0.32
2011 Liu XS, Song B, Elzey BD, Ratliff TL, Konieczny SF, Cheng L, Ahmad N, Liu X. Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation. The Journal of Biological Chemistry. 286: 35795-800. PMID 21890624 DOI: 10.1074/jbc.C111.269050  0.32
2011 Svensson RU, Haverkamp JM, Thedens DR, Cohen MB, Ratliff TL, Henry MD. Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer. The American Journal of Pathology. 179: 502-12. PMID 21703427 DOI: 10.1016/j.ajpath.2011.03.014  0.32
2011 Haverkamp JM, Charbonneau B, Crist SA, Meyerholz DK, Cohen MB, Snyder PW, Svensson RU, Henry MD, Wang HH, Ratliff TL. An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate. The Prostate. 71: 1139-50. PMID 21656824 DOI: 10.1002/pros.21327  0.32
2011 Haverkamp JM, Crist SA, Elzey BD, Cimen C, Ratliff TL. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. European Journal of Immunology. 41: 749-59. PMID 21287554 DOI: 10.1002/eji.201041069  0.32
2011 Elzey BD, Ratliff TL, Sowa JM, Crist SA. Platelet CD40L at the interface of adaptive immunity. Thrombosis Research. 127: 180-3. PMID 21075431 DOI: 10.1016/j.thromres.2010.10.011  0.32
2011 Wang X, Zhao M, Nolte DD, Ratliff TL. Prostate specific antigen detection in patient sera by fluorescence-free BioCD protein array. Biosensors & Bioelectronics. 26: 1871-5. PMID 20236816 DOI: 10.1016/j.bios.2010.02.009  0.32
2010 Eberlin LS, Dill AL, Costa AB, Ifa DR, Cheng L, Masterson T, Koch M, Ratliff TL, Cooks RG. Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry. Analytical Chemistry. 82: 3430-4. PMID 20373810 DOI: 10.1021/ac9029482  0.32
2009 Sowa JM, Crist SA, Ratliff TL, Elzey BD. Platelet influence on T- and B-cell responses. Archivum Immunologiae Et Therapiae Experimentalis. 57: 235-41. PMID 19578816 DOI: 10.1007/s00005-009-0032-y  0.32
2009 Simons CM, De Young BR, Griffith TS, Ratliff TL, Jones E, Mallapragada SK, Wald M. Early microrecanalization of vas deferens following biodegradable graft implantation in bilaterally vasectomized rats. Asian Journal of Andrology. 11: 373-8. PMID 19349949 DOI: 10.1038/aja.2008.8  0.32
2008 Elzey BD, Schmidt NW, Crist SA, Kresowik TP, Harty JT, Nieswandt B, Ratliff TL. Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood. 111: 3684-91. PMID 18256321 DOI: 10.1182/blood-2007-05-091728  0.32
2008 Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood. 111: 5028-36. PMID 18198347 DOI: 10.1182/blood-2007-06-097410  0.32
2008 Crist SA, Sprague DL, Ratliff TL. Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes. Blood. 111: 3553-61. PMID 18180380 DOI: 10.1182/blood-2007-05-088161  0.32
2008 Duchene DA, Gallagher BL, Ratliff TL, Winfield HN. Systemic and cell-specific immune response to laparoscopic and open nephrectomy in porcine model. Journal of Endourology / Endourological Society. 22: 113-20. PMID 18177243 DOI: 10.1089/end.2007.9859  0.32
2008 Stahl BC, Ratliff TL, De Young BR, Wald M. Involvement of growth factors in the process of post-vasectomy micro-recanalization. The Journal of Urology. 179: 376-80. PMID 18006005 DOI: 10.1016/j.juro.2007.08.093  0.32
2008 Haverkamp J, Charbonneau B, Ratliff TL. Prostate inflammation and its potential impact on prostate cancer: a current review. Journal of Cellular Biochemistry. 103: 1344-53. PMID 17955503 DOI: 10.1002/jcb.21536  0.32
2008 Sinn HW, Elzey BD, Jensen RJ, Zhao X, Zhao W, Ratliff TL. The fibronectin attachment protein of bacillus Calmette-Guerin (BCG) mediates antitumor activity. Cancer Immunology, Immunotherapy : Cii. 57: 573-9. PMID 17786441 DOI: 10.1007/s00262-007-0397-x  0.32
2008 Elzey BD, Crist SA, Sprague DL, Ratliff TL. Response: Are PDMVs the biologically active source of CD154 in ATR? Blood. 112: 4780-4781. DOI: 10.1182/blood-2008-07-165357  0.32
2007 Redmond WL, Gough MJ, Charbonneau B, Ratliff TL, Weinberg AD. Defects in the acquisition of CD8 T cell effector function after priming with tumor or soluble antigen can be overcome by the addition of an OX40 agonist. Journal of Immunology (Baltimore, Md. : 1950). 179: 7244-53. PMID 18025166  0.32
2007 Sprague DL, Sowa JM, Elzey BD, Ratliff TL. The role of platelet CD154 in the modulation in adaptive immunity. Immunologic Research. 39: 185-93. PMID 17917065 DOI: 10.1007/s12026-007-0074-3  0.32
2006 Grant JF, Iwasawa T, Sinn HW, Siemens DR, Griffith TS, Takacs EB, Ratliff TL. Induction of protective immunity to RM-1 prostate cancer cells with ALVAC-IL-2/IL-12/TNF-alpha combination therapy. International Journal of Cancer. 119: 2632-41. PMID 16991124 DOI: 10.1002/ijc.22220  0.32
2006 Lubaroff DM, Konety B, Link BK, Ratliff TL, Madsen T, Shannon M, Ecklund D, Williams RD. Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer. Human Gene Therapy. 17: 220-9. PMID 16454655 DOI: 10.1089/hum.2006.17.220  0.32
2006 Lees JR, Charbonneau B, Swanson AK, Jensen R, Zhang J, Matusik R, Ratliff TL. Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells. Immunology. 117: 248-61. PMID 16423061 DOI: 10.1111/j.1365-2567.2005.02293.x  0.32
2006 McFarland DC, Zhang C, Thomas HC, T L R. Confounding effects of platelets on flow cytometric analysis and cell-sorting experiments using blood-derived cells. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. 69: 86-94. PMID 16419063 DOI: 10.1002/cyto.a.20207  0.32
2006 Lees JR, Charbonneau B, Hayball JD, Diener K, Brown M, Matusik R, Cohen MB, Ratliff TL. T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. The Prostate. 66: 578-90. PMID 16388504 DOI: 10.1002/pros.20307  0.32
2006 Ratliff TL. Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP: Commentary Journal of Urology. 175: 1172-1173. DOI: 10.1016/S0022-5347(05)00628-2  0.32
2006 Ratliff TL. Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase: Commentary Journal of Urology. 175: 1172. DOI: 10.1016/S0022-5347(05)00627-0  0.32
2006 Ratliff TL. A transcriptional signaling pathway in the IFN system mediated by 2′-5′-oligoadenylate activation of RNase L: Commentary Journal of Urology. 175: 1171-1172. DOI: 10.1016/S0022-5347(05)00626-9  0.32
2006 Ratliff TL. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer: Commentary Journal of Urology. 175: 1171. DOI: 10.1016/S0022-5347(05)00625-7  0.32
2006 Ratliff TL. Free DNA in urine: A new marker for bladder cancer? Preliminary data - Commentary Journal of Urology. 175: 787. DOI: 10.1016/S0022-5347(05)00445-3  0.32
2006 Ratliff TL. Detection of prostate cancer with a blood-based assay for early prostate cancer antigen: Commentary Journal of Urology. 175: 389. DOI: 10.1016/S0022-5347(05)00111-4  0.32
2006 Ratliff TL. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: Genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice - Commentary Journal of Urology. 175: 388-389. DOI: 10.1016/S0022-5347(05)00110-2  0.32
2006 Ratliff TL. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence: Commentary Journal of Urology. 175: 388. DOI: 10.1016/S0022-5347(05)00109-6  0.32
2006 Ratliff TL. Identification of novel VHL target genes and relationship to hypoxic response pathways: Commentary Journal of Urology. 175: 387. DOI: 10.1016/S0022-5347(05)00108-4  0.32
2006 Ratliff TL. Biological surrogate end-points in cancer trials: Potential uses, benefits and pitfalls - Commentary Journal of Urology. 175: 387. DOI: 10.1016/S0022-5347(05)00107-2  0.32
2005 Elzey BD, Sprague DL, Ratliff TL. The emerging role of platelets in adaptive immunity. Cellular Immunology. 238: 1-9. PMID 16442516 DOI: 10.1016/j.cellimm.2005.12.005  0.32
2005 Ratliff TL. CDC91L1 (PIG-U) mRNA expression in urothelial cell carcinomas. The Journal of Urology. 174: 2066. PMID 16217398  0.32
2005 Ratliff TL. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. The Journal of Urology. 174: 2066. PMID 16217397  0.32
2005 Ratliff TL. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro. The Journal of Urology. 174: 2065. PMID 16217396 DOI: 10.1097/01.ju.0000183078.11059.00  0.32
2005 Jobe SM, Leo L, Eastvold JS, Dickneite G, Ratliff TL, Lentz SR, Di Paola J. Role of FcRgamma and factor XIIIA in coated platelet formation. Blood. 106: 4146-51. PMID 16105983 DOI: 10.1182/blood-2005-03-1223  0.32
2005 Ratliff TL. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a toll-like receptor-4-dependent mechanism. The Journal of Urology. 174: 1150. PMID 16094086  0.32
2005 Ratliff TL. Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin. The Journal of Urology. 174: 1150. PMID 16094085  0.32
2005 Ratliff TL. Estrogen receptor alpha and imprinting of the neonatal mouse ventral prostate by estrogen. The Journal of Urology. 174: 1149. PMID 16094084 DOI: 10.1097/01.ju.0000171853.20105.60  0.32
2005 Ratliff TL. Mutation of the androgen receptor causes oncogenic transformation of the prostate. The Journal of Urology. 174: 1149. PMID 16094083  0.32
2005 Elzey BD, Grant JF, Sinn HW, Nieswandt B, Waldschmidt TJ, Ratliff TL. Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. Journal of Leukocyte Biology. 78: 80-4. PMID 15899982 DOI: 10.1189/jlb.1104669  0.32
2005 Ratliff TL. Identification of pretreatment agents to enhance adenovirus infection of bladder epithelium. The Journal of Urology. 173: 2198-9. PMID 15879887 DOI: 10.1097/01.ju.0000161260.17477.99  0.32
2005 Ratliff TL. Contribution of mast cells to bacterial clearance and their proliferation during experimental cystitis induced by type 1 fimbriated E. coli. The Journal of Urology. 173: 662. PMID 15643284 DOI: 10.1097/01.ju.0000150556.50717.77  0.32
2005 Ratliff TL. Urological survey - Uro-Science Journal of Urology. 174: 1497-1499. DOI: 10.1097/01.ju.0000175573.97783.e8  0.32
2005 Ratliff TL. Urological survey: Uro-science Journal of Urology. 174: 394-395. DOI: 10.1097/01.ju.0000164340.35878.17  0.32
2005 Ratliff TL. Uro-science Journal of Urology. 173: 1825-1826. DOI: 10.1097/01.ju.0000159586.83680.ed  0.32
2004 Middleton AM, Chadwick MV, Nicholson AG, Dewar A, Groger RK, Brown EJ, Ratliff TL, Wilson R. Inhibition of adherence of Mycobacterium avium complex and Mycobacterium tuberculosis to fibronectin on the respiratory mucosa. Respiratory Medicine. 98: 1203-6. PMID 15588041 DOI: 10.1016/j.rmed.2004.04.013  0.32
2004 Crist SA, Elzey BD, Ludwig AT, Griffith TS, Staack JB, Lentz SR, Ratliff TL. Expression of TNF-related apoptosis-inducing ligand (TRAIL) in megakaryocytes and platelets. Experimental Hematology. 32: 1073-81. PMID 15539085 DOI: 10.1016/j.exphem.2004.07.022  0.32
2003 Siemens DR, Crist S, Austin JC, Tartaglia J, Ratliff T. Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model. The Journal of Urology. 170: 979-84. PMID 12913754 DOI: 10.1097/01.ju.0000070925.10039.23  0.32
2003 Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, Stein CS, Nieswandt B, Wang Y, Davidson BL, Ratliff TL. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity. 19: 9-19. PMID 12871635 DOI: 10.1016/S1074-7613(03)00177-8  0.32
2003 Crist SA, Griffith TS, Ratliff TL. Structure/function analysis of the murine CD95L promoter reveals the identification of a novel transcriptional repressor and functional CD28 response element. The Journal of Biological Chemistry. 278: 35950-8. PMID 12855690 DOI: 10.1074/jbc.M306220200  0.32
2003 Kausch I, Lingnau A, Endl E, Sellmann K, Deinert I, Ratliff TL, Jocham D, Sczakiel G, Gerdes J, Böhle A. Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo. International Journal of Cancer. Journal International Du Cancer. 105: 710-6. PMID 12740923 DOI: 10.1002/ijc.11111  0.32
2003 Nadler R, Luo Y, Zhao W, Ritchey JK, Austin JC, Cohen MB, O'Donnell MA, Ratliff TL. Interleukin 10 induced augmentation of delayed-type hypersensitivity (DTH) enhances Mycobacterium bovis bacillus Calmette-Guérin (BCG) mediated antitumour activity Clinical and Experimental Immunology. 131: 206-216. PMID 12562379 DOI: 10.1046/j.1365-2249.2003.02071.x  0.32
2003 Siemens DR, Ratliff TL. Are Vaccinations for Prostate Cancer Realistic? Prostate Cancer: Science and Clinical Practice. 545-554. DOI: 10.1016/B978-012286981-5/50060-4  0.32
2002 Broghammer EL, Ratliff TL. Immunotherapy of urologic tumors: principles and progress. Urologic Oncology. 7: 45-56. PMID 12474522 DOI: 10.1016/S1078-1439(01)00151-X  0.32
2002 Middleton AM, Chadwick MV, Nicholson AG, Dewar A, Groger RK, Brown EJ, Ratliff TL, Wilson R. Interaction of Mycobacterium tuberculosis with human respiratory mucosa. Tuberculosis (Edinburgh, Scotland). 82: 69-78. PMID 12356457 DOI: 10.1054/tube.2002.0324  0.32
2002 Kausch I, Ardelt P, Böhle A, Ratliff TL. Immune gene therapy in urology. Current Urology Reports. 3: 82-9. PMID 12084224  0.32
2002 Lutgendorf SK, Kreder KJ, Rothrock NE, Hoffman A, Kirschbaum C, Sternberg EM, Zimmerman MB, Ratliff TL. Diurnal cortisol variations and symptoms in patients with interstitial cystitis. The Journal of Urology. 167: 1338-43. PMID 11832727  0.32
2001 Elzey BD, Robert Siemens D, Ratliff TL, Lubaroff DM. Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors International Journal of Cancer. 94: 842-849. PMID 11745487 DOI: 10.1002/ijc.1556  0.32
2001 Siemens DR, Ratliff TL. Vaccines in urologic malignancies Urological Research. 29: 152-162. PMID 11482438 DOI: 10.1007/s002400100178  0.32
2001 Griffith TS, Kawakita M, Tian J, Ritchey J, Tartaglia J, Sehgal I, Thompson TC, Zhao W, Ratliff TL. Inhibition of murine prostate tumor growth and activation of immmunoregulatory cells with recombinant canarypox viruses Journal of the National Cancer Institute. 93: 998-1007. PMID 11438565  0.32
2001 Lutgendorf SK, Kreder KJ, Rothrock NE, Ratliff TL, Zimmerman B. A laboratory stress model for examining stress and symptomatology in interstitial cystitis patients. Urology. 57: 122. PMID 11378109  0.32
2001 Rothrock NE, Lutgendorf SK, Kreder KJ, Ratliff TL, Zimmerman B. Daily stress and symptom exacerbation in interstitial cystitis patients. Urology. 57: 122. PMID 11378108  0.32
2001 Brandau S, Riemensberger J, Jacobsen M, Kemp D, Zhao W, Zhao X, Jocham D, Ratliff TL, Bhle A. NK cells are essential for effective BCG immunotherapy International Journal of Cancer. 92: 697-702. PMID 11340575 DOI: 10.1002/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z  0.32
2001 Siemens DR, Austin JC, See WA, Tartaglia J, Ratliff TL. Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium Journal of Urology. 165: 667-671. PMID 11176455 DOI: 10.1097/00005392-200102000-00091  0.32
2001 Siemens DR, Elzey BD, Lubaroff DM, Bohlken C, Jensen RJ, Swanson AK, Ratliff TL. Cutting edge: restoration of the ability to generate CTL in mice immune to adenovirus by delivery of virus in a collagen-based matrix. Journal of Immunology (Baltimore, Md. : 1950). 166: 731-5. PMID 11145643  0.32
2000 Warren TL, Bhatia SK, Acosta AM, Dahle CE, Ratliff TL, Krieg AM, Weiner GJ. APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells. Journal of Immunology (Baltimore, Md. : 1950). 165: 6244-51. PMID 11086059  0.32
2000 Ratliff TL. Role of animal models in understanding intravesical therapy with Bacille Calmette-Guérin Clinical Infectious Diseases. 31. PMID 11010834 DOI: 10.1086/314065  0.32
2000 Lutgendorf SK, Kreder KJ, Rothrock NE, Ratliff TL, Zimmerman B. Stress and symptomatology in patients with interstitial cystitis: a laboratory stress model. The Journal of Urology. 164: 1265-9. PMID 10992377  0.32
2000 Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 165: 2886-94. PMID 10946322  0.32
2000 Zhao W, Schorey JS, Bong-Mastek M, Ritchey J, Brown EJ, Ratliff TL. Role of a bacillus calmette-guerin fibronectin attachment protein in BCG-induced antitumor activity International Journal of Cancer. 86: 83-88. PMID 10728599 DOI: 10.1002/(SICI)1097-0215(20000401)86:1<83::AID-IJC13>3.0.CO;2-R  0.32
2000 Siemens DR, Austin JC, Hedican SP, Tartaglia J, Ratliff TL. Viral vector delivery in solid-state vehicles: Gene expression in a murine prostate cancer model Journal of the National Cancer Institute. 92: 403-412. PMID 10699070  0.32
1999 Ratliff TL. Overview of infection, immunology, and interstitial cystitis in the bladder Advances in Experimental Medicine and Biology. 462: 323-324. PMID 10599435  0.32
1999 Zhao W, Schorey JS, Groger R, Allen PM, Brown EJ, Ratliff TL. Characterization of the fibronectin binding motif for a unique mycobacterial fibronectin attachment protein, FAP Journal of Biological Chemistry. 274: 4521-4526. PMID 9988684 DOI: 10.1074/jbc.274.8.4521  0.32
1998 Ratliff TL, Rao GS, Ritchey JK. Invasive bladder carcinoma: Progress in basic research, surgical and medical therapy European Urology. 33: 15. PMID 9615201 DOI: 10.1159/000052255  0.32
1998 Belldegrun AS, Franklin JR, O'Donnell MA, Gomella LG, Klein E, Neri R, Nseyo UO, Ratliff TL, Williams RD. Superficial bladder cancer: The role of interferon-α Journal of Urology. 159: 1793-1801. PMID 9598463  0.32
1997 Kawakita M, Yoshida O, Ratliff TL. Poxvirus vectors for gene transfer Acta Urologica Japonica. 43: 835-838. PMID 9436032  0.32
1997 Keetch DW, Andriole GL, Ratliff TL, Catalona WJ. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting Urology. 50: 901-905. PMID 9426721 DOI: 10.1016/S0090-4295(97)00453-6  0.32
1997 Arcangeli CG, Smith DS, Ratliff TL, Catalona WJ. Stability of serum total and free prostate specific antigen under varying storage intervals and temperatures. The Journal of Urology. 158: 2182-7. PMID 9366340 DOI: 10.1016/S0022-5347(01)68191-6  0.32
1997 Ornstein DK, Smith DS, Rao GS, Basler JW, Ratliff TL, Catalona WJ. Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers. The Journal of Urology. 157: 2179-82. PMID 9146610  0.32
1997 Hofmeister MA, He F, Ratliff TL, Mahoney T, Becich MJ. Mast cells and nerve fibers in interstitial cystitis (IC): an algorithm for histologic diagnosis via quantitative image analysis and morphometry (QIAM). Urology. 49: 41-7. PMID 9146000 DOI: 10.1016/S0090-4295(99)80330-6  0.32
1997 Ornstein DK, Rao GS, Smith DS, Ratliff TL, Basler JW, Catalona WJ. Effect of digital rectal examination and needle biopsy on serum total and percentage of free prostate specific antigen levels. The Journal of Urology. 157: 195-8. PMID 8976249  0.32
1996 Wolf JS, Soble JJ, Ratliff TL, Clayman RV. Ureteral cell cultures II: Collagen production and response to pharmacologic agents Journal of Urology. 156: 2067-2072. PMID 8911392 DOI: 10.1016/S0022-5347(01)65437-5  0.32
1996 Schorey JS, Holsti MA, Ratliff TL, Allen PM, Brown EJ. Characterization of the fibronectin-attachment protein of Mycobacterium avium reveals a fibronectin-binding motif conserved among mycobacteria Molecular Microbiology. 21: 321-329. PMID 8858587  0.32
1996 Wang R, Rogers AM, Ratliff TL, Russell JH. CD95-dependent bystander lysis caused by CD4+ T helper 1 effectors. Journal of Immunology (Baltimore, Md. : 1950). 157: 2961-8. PMID 8816403  0.32
1996 Wolf JS, Soble JJ, Ratliff TL, Clayman RV. Ureteral cell cultures. I. Characterization and cellular interactions Journal of Urology. 156: 1198-1203. PMID 8709346  0.32
1996 Ratliff TL, Kawakita M, Tartaglia J, Paoletti E. Canary-pox (ALVAC) virus-mediated cytokine gene therapy induces tumour specific and non-specific immunity against mouse prostate tumor Acta Urologica Belgica. 64: 85. PMID 8701820  0.32
1996 Ratliff TL. Molecular research in cancer: future clinical applications Acta Urologica Belgica. 64: 53-55. PMID 8701813  0.32
1996 Abi-Aad AS, Ratliff TL. Gene therapy Acta Urologica Belgica. 64: 51-52. PMID 8701812  0.32
1996 Ratliff TL, Hudson MA. BCG treatment: Current status Acta Urologica Belgica. 64: 25. PMID 8701802  0.32
1995 Ratliff TL, Klutke CG, Hofmeister M, He F, Russell JH, Becich MJ. Role of the immune response in interstitial cystitis Clinical Immunology and Immunopathology. 74: 209-216. PMID 7859410 DOI: 10.1006/clin.1995.1031  0.32
1995 Schorey JS, Li Q, McCourt DW, Bong-Mastek M, Clark-Curtiss JE, Ratliff TL, Brown EJ. A Mycobacterium leprae gene encoding a fibronectin binding protein is used for efficient invasion of epithelial cells and Schwann cells Infection and Immunity. 63: 2652-2657. PMID 7790081  0.32
1995 Humphrey PA, Zhu X, Zarnegar R, Swanson PE, Ratliff TL, Vollmer RT, Day ML. Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. The American Journal of Pathology. 147: 386-96. PMID 7639332  0.32
1995 Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, Ratliff TL, Nadler RB. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. Jama. 274: 1214-20. PMID 7563511 DOI: 10.1001/jama.274.15.1214  0.32
1995 Lamm DL, van der Meijden AP, Akaza H, Brendler C, Hedlund PO, Mizutani Y, Ratliff TL, Robinson MR, Shinka T. Intravesical chemotherapy and immunotherapy: how do we assess their effectiveness and what are their limitations and uses? International Journal of Urology : Official Journal of the Japanese Urological Association. 2: 23-35. PMID 7553302  0.32
1995 Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. The Journal of Urology. 154: 407-13. PMID 7541857 DOI: 10.1016/S0022-5347(01)67064-2  0.32
1995 Ratliff TL. Commentary on interleukin-6 and BCG therapy Journal of Urology. 154: 346. DOI: 10.1016/S0022-5347(01)67043-5  0.32
1995 Hudson MA, Ratliff TL. Failure of intravesical interferon-alfa-2b for the treatment of patients with superficial bladder cancer previously failing intravesical BCG Therapy Urologic Oncology: Seminars and Original Investigations. 1: 115-118. DOI: 10.1016/1078-1439(95)00039-K  0.32
1995 Ratliff TL. Reply Clinical Immunology and Immunopathology. 77: 116.  0.32
1994 Ratliff TL, Klutke CG, McDougall EM. The etiology of interstitial cystitis Urologic Clinics of North America. 21: 21-30. PMID 8284842  0.32
1994 Keetch DW, Humphrey P, Ratliff TL. Development of a mouse model for nonbacterial prostatitis Journal of Urology. 152: 247-250. PMID 8201676  0.32
1994 Swerdlow RD, Ratliff TL, La Regina M, Ritchey JK, Ebert RF. Immunotherapy with keyhole limpet hemocyanin: Efficacy and safety in the MB-49 intravesical murine bladder tumor model Journal of Urology. 151: 1718-1722. PMID 8189604  0.32
1994 Nadler RB, Catalona WJ, Hudson MA, Ratliff TL. Durability of the tumor-free response for intravesical bacillus Calmette- Guerin therapy Journal of Urology. 152: 367-373. PMID 8015073  0.32
1994 Ratliff TL, Ritchey JK, Brandhorst J, Hanna MG. Time-dependent aggregation of reconstituted BCG vaccine Journal of Urology. 152: 2147-2150. PMID 7966704  0.32
1994 Catalona WJ, Hudson MA, Scardino PT, Richie JP, Ahmann FR, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC. Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: Receiver operating characteristic curves Journal of Urology. 152: 2037-2042. PMID 7525995  0.32
1994 Catalona WJ, Richie JP, DeKernion JB, Ahmann FR, Ratliff TL, Dalkin BL, Kavoussi LR, MacFarlane MT, Southwick PC. Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: Receiver operating characteristic curves Journal of Urology. 152: 2031-2036. PMID 7525994  0.32
1994 Flanigan RC, Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC. Accuracy of digital rectal examination and transrectal ultrasonography in localizing prostate cancer Journal of Urology. 152: 1506-1509. PMID 7523707  0.32
1994 Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, DeKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men Journal of Urology. 151: 1283-1290. PMID 7512659  0.32
1993 Ratliff TL, McCarthy R, Telle WB, Brown EJ. Purification of a mycobacterial adhesin for fibronectin Infection and Immunity. 61: 1889-1894. PMID 8478078  0.32
1993 Kuroda K, Brown EJ, Telle WB, Russell DG, Ratliff TL. Characterization of the internalization of Bacillus Calmette-Guerin by human bladder tumor cells Journal of Clinical Investigation. 91: 69-76. PMID 8423234  0.32
1993 Goldstein DS, Lu ML, Hattori T, Ratliff TL, Loughlin KR, Kavoussi LR. Inhibition of peritoneal tumor-cell implantation: Model for laparoscopic cancer surgery Journal of Endourology. 7: 237-241. PMID 8358421  0.32
1993 Ratliff TL, Ritchey JK, Yuan JJJ, Andriole GL, Catalona WJ. T-cell subsets required for intravesical BCG immunotherapy for bladder cancer Journal of Urology. 150: 1018-1023. PMID 8102183  0.32
1993 Richie JP, Catalona WJ, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, Dekernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination Urology. 42: 365-374. PMID 7692657 DOI: 10.1016/0090-4295(93)90359-I  0.32
1993 Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. Jama. 270: 948-54. PMID 7688438 DOI: 10.1001/jama.1993.03510080052031  0.32
1992 Bullock AD, Becich MJ, Klutke CG, Ratliff TL. Experimental autoimmune cystitis: A potential murine model for ulcerative interstitial cystitis Journal of Urology. 148: 1951-1956. PMID 1433651  0.32
1992 Ratliff TL. Role of the immune response in BCG for bladder cancer European Urology. 21: 17-21. PMID 1396942  0.32
1992 Yuan JJ, Coplen DE, Petros JA, Figenshau RS, Ratliff TL, Smith DS, Catalona WJ. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. The Journal of Urology. 147: 810-4. PMID 1371553  0.32
1992 Ratliff TL. Mechanisms of action of BCG in superficial bladder cancer Progress in Clinical and Biological Research. 378: 103-109. PMID 1301570  0.32
1991 Hudson LA, Brown EJ, Ritchey JK, Ratliff TL. Modulation of Fibronectin-mediated Bacillus Calmette-Guürin (BCG Attachment to Murine Bladder Mucosa by Drugs Influencing the Coagulation Pathways Cancer Research. 51: 3726-3732. PMID 2065329  0.32
1991 Becich MJ, Carroll S, Ratliff TL. Internalization of bacille calmette-guerin by bladder tumor cells Journal of Urology. 145: 1316-1324. PMID 2033723  0.32
1991 Coplen DE, Brown EJ, McGarr J, Ratliff TL. Characterization of fibronectin attachment by a human transitional cell carcinoma line, T24 Journal of Urology. 145: 1312-1315. PMID 2033722  0.32
1991 Ratliff TL. Bacillus Calmette-Guerin (BCG): Mechanism of action in superficial bladder cancer Urology. 37: 8-11. PMID 2021034  0.32
1991 Hudson MLA, Ratliff TL. BCG therapy for superficial bladder cancer: Fundamental aspects In Vivo. 5: 643-646. PMID 1810450  0.32
1991 Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. The New England Journal of Medicine. 324: 1156-61. PMID 1707140 DOI: 10.1056/NEJM199104253241702  0.32
1991 Ratliff TL, Hudson MA, Catalona WJ. Strategy for improving therapy of superficial bladder cancer World Journal of Urology. 9: 95-98. DOI: 10.1007/BF00184040  0.32
1990 Catalona WJ, Ratliff TL. Bacillus Calmette-Guérin and superficial bladder cancer. Clinical experience and mechanism of action Surgery Annual. 22: 363-378. PMID 2408170  0.32
1990 Kavoussi LR, Brown EJ, Ritchey JK, Ratliff TL. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response Journal of Clinical Investigation. 85: 62-67. PMID 2404029  0.32
1990 Coplen DE, Marcus MD, Myers JA, Ratliff TL, Catalona WJ. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: Analysis of possible predictors of response free of tumor Journal of Urology. 144: 652-657. PMID 2388321  0.32
1990 Hudson MA, Yuan JJ, Catalona WJ, Ratliff TL. Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors Journal of Urology. 144: 1362-1364. PMID 2231927  0.32
1990 Hudson MA, Ritchey JK, Catalona WJ, Brown EJ, Ratliff TL. Comparison of the Fibronectin-binding Ability and Antitumor Efficacy of Various Mycobacteria Cancer Research. 50: 3843-3847. PMID 2191767  0.32
1990 Bahnson RR, Ratliff TL. In vitro and in vivo anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) in a mouse bladder tumor (MBT-2) Journal of Urology. 144: 172-175. PMID 2113589  0.32
1990 Hudson MLA, Catalona WJ, Ratliff TL. Adverse effect of fibrin clot inhibitors on intravesical BCG therapy for superficial bladder tumors Surgical Forum. 41: 698-700.  0.32
1989 Fleischmann JD, Toossi Z, Ellner JJ, Wentworth DB, Ratliff TL, Imbembo AL. Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancer Cancer. 64: 1447-1454. PMID 2789094  0.32
1989 Ratliff TL. Mechanisms of action of intravesical BCG for bladder cancer Progress in Clinical and Biological Research. 310: 107-122. PMID 2672010  0.32
1989 Hudson MA, Catalona WJ, Ritchey JK, Aslanzadeh J, Brown EJ, Ratliff TL. Choice of an optimal diluent for intravesical bacillus Calmette-Guerin administration Journal of Urology. 142: 1438-1441. PMID 2585615  0.32
1989 Mikkelsen DJ, Ratliff TL. Mechanisms of action of intravesical bacillus Calmette-Guerin for bladder cancer Cancer Treatment and Research. 46: 195-211. PMID 2577190  0.32
1989 Aslanzadeh J, Brown EJ, Quillin SP, Richey JK, Ratliff TL. Characterization of soluble fibronectin binding to Bacille Calmette-Guerin Journal of General Microbiology. 135: 2735-2741. PMID 2534398  0.32
1989 Kavoussi LR, Ruesing RA, Hudson MA, Catalona WJ, Ratliff TL. Effect of tumor necrosis factor and interferon gamma on human renal carcinoma cell line growth Journal of Urology. 142: 875-878. PMID 2504941  0.32
1989 Jacobs AJ, Dawoud L, Kovacs Z, Ratliff TL. Inhibition of proliferation of lines derived from human cervical carcinomas by cytotoxic drugs and by recombinant interferons Gynecologic Oncology. 32: 31-36. PMID 2491828 DOI: 10.1016/0090-8258(89)90845-7  0.32
1989 Dow JA, Di Sant'Agnese PA, Cockett ATK, Ratliff TL, Lamm DL. Expression of blood group precursor T antigen as a prognostic marker for human bladder cancer treated by bacillus Calmette-Guerin and interleukin-2 Journal of Urology. 142: 978-982. PMID 2477561  0.32
1988 Torrence RJ, Kavoussi LR, Catalona WJ, Ratliff TL. Prognostic factors in patients treated with intravesical bacillus Calmette-Guerin for superficial bladder cancer Journal of Urology. 139: 941-944. PMID 3361668  0.32
1988 Kavoussi LR, Torrence RJ, Gillen DP, Hudson MA, Haaff EO, Dresner SM, Ratliff TL, Catalona WJ. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors Journal of Urology. 139: 935-940. PMID 3361667  0.32
1988 Ratliff TL, McGarr JA, Abou-Zeid C, Rook GAW, Stanford JL, Aslanzadeh J, Brown EJ. Attachment of mycobacteria to fibronectin-coated surfaces Journal of General Microbiology. 134: 1307-1313. PMID 3143807  0.32
1988 Abou-Zeid C, Ratliff TL, Wiker HG, Harboe M, Bennedsen J, Rook GAW. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG Infection and Immunity. 56: 3046-3051. PMID 3141278  0.32
1988 Abou-Zeid C, Smith I, Grange JM, Ratliff TL, Steele J, Rook GAW. The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies Journal of General Microbiology. 134: 531-538. PMID 3139828  0.32
1988 Bahnson RR, Ratliff TL. Inhibition of mouse bladder tumor proliferation by alpha difluoromethylornithine and interferon in vitro and in vivo Journal of Urology. 139: 1367-1371. PMID 3131549  0.32
1988 Bahnson R, Ratliff TL. Effects of interferon in combination with cytotoxic drugs on mouse bladder tumor (MBT-2) growth in vitro and in vivo Journal of Urology. 140: 656-659. PMID 2457714  0.32
1987 Catalona WJ, Hudson MA, Gillen DP, Andriole GL, Ratliff TL. Risks and benefits of repeated courses of intravesical bacillus Calmette-Gurerin therapy for superficial bladder cancer Journal of Urology. 137: 220-224. PMID 3806806  0.32
1987 Ratliff TL, Palmer JO, McGarr JA, Brown EJ. Intravesical Bacillus Calmette-Guérin Therapy for Murine Bladder Tumors: Initiation of the Response by Fibronectin-mediated Attachment of Bacillus Calmette-Guérin Cancer Research. 47: 1762-1766. PMID 3545453  0.32
1987 Ratliff TL, Gillen D, Catalona WJ. Requirement of a thymus dependent immune response for BCG-mediated antitumor activity Journal of Urology. 137: 155-158. PMID 3491909  0.32
1987 Hudson MA, Ratliff TL, Gillen DP, Haaff EO, Dresner SM, Catalona WJ. Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial Journal of Urology. 138: 295-298. PMID 3298694  0.32
1987 Andriole GL, Ratliff TL. Effect of interleukin-2 and lymphokine-activated killer cells on the development of bladder tumors in a murine model Surgical Forum. 38: 683-684.  0.32
1986 Lage JM, Bauer WC, Kelley DR, Ratliff TL, Catalona WJ. Histological parameters and pitfalls in the interpretation of bladder biopsies in bacillus Calmette-Guerin treatment of superficial bladder cancer Journal of Urology. 135: 916-919. PMID 3959240  0.32
1986 Haaff EO, Dresner SM, Ratliff TL, Catalona WJ. Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder Journal of Urology. 136: 820-824. PMID 3761438  0.32
1986 Ratliff TL, Shapiro A, Catalona WJ. Inhibition of murine bladder tumor growth by bacille Calmette-Guerin: Lack of a role of natural killer cells Clinical Immunology and Immunopathology. 41: 108-115. PMID 3527506 DOI: 10.1016/0090-1229(86)90055-3  0.32
1986 Kelley DR, Haaff EO, Becich M, Lage J, Bauer WC, Dresner SM, Catalona WJ, Ratliff TL. Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin Journal of Urology. 135: 268-271. PMID 3511285  0.32
1986 Haaff EO, Catalona WJ, Ratliff TL. Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG Journal of Urology. 136: 970-974. PMID 3489840  0.32
1986 Ratliff TL, Haaff EO, Catalona WJ. Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancer Clinical Immunology and Immunopathology. 40: 375-379. PMID 3487405 DOI: 10.1016/0090-1229(86)90043-7  0.32
1985 Fleischmann J, Heston WD, Bander NH, Bauer WC, Janney C, Ratliff TL, Fair WR. Human renal cell carcinoma xenograft: morphology, growth and chemosensitivities. The Journal of Urology. 134: 570-4. PMID 3928905  0.32
1985 Kelley DR, Ratliff TL, Catalona WJ, Shapiro A, Lage JM, Bauer WC, Haaff EO, Dresner SM. Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer: Effect of bacillus Calmette-Guerin viability on treatment results Journal of Urology. 134: 48-53. PMID 3892051  0.32
1985 Howe RC, Milstone DS, Ratliff TL, Russell JH. Interleukin 2-mediated induction of lytic activity in a cloned murine CTL line Journal of Immunology. 134: 2414-2418. PMID 2579143  0.32
1985 Haff EO, Dresner SM, Kelley DR, Ratliff TL, Shapiro A, Catalona WJ. Role of immunotherapy in the prevention of recurrence and invasion of urothelial bladder tumors: a review World Journal of Urology. 3: 76-85. DOI: 10.1007/BF00326713  0.32
1985 Ratliff TL, Dresner SM. Effects of interferon alpha, gamma and difluoromethylornithine on the proliferation of human renal cell adenocarcinoma cells Federation Proceedings. 44.  0.32
1984 Ratliff TL, Kadmon D, Shapiro A, Heston WDW, Jacobs AJ. Inhibition of Mouse Bladder Tumor Proliferation by Murine lnterferon-7 and Its Synergism with Interferon-β Cancer Research. 44: 4377-4381. PMID 6432311  0.32
1984 Heston WDW, Fleischmann J, Tackett RE, Ratliff TL. Effects of α-Difluoromethylornithine and Recombinant Interferon-α2 on the Growth of a Human Renal Cell Adenocarcinoma Xenograft in Nude Mice Cancer Research. 44: 3220-3225. PMID 6430546  0.32
1984 Ratliff TL, Catalona WJ, Kelley DR, Shapiro A. Heightened Interferon-γ Production by Mononuclear Cells from Bladder Cancer Patients Cancer Research. 44: 3140-3143. PMID 6426791  0.32
1984 Shapiro A, Ratliff TL, Oakley DM, Catalona WJ. Comparison of the efficacy of intravesical, bacillus Calmette-Guerin with thiotepa, mitomycin C, poly I:C/poly-L-lysine and cis platinum in murine bladder cancer Journal of Urology. 131: 139-142. PMID 6418894  0.32
1984 Shapiro A, Kelley DR, Oakley DM, Catalona WJ, Ratliff TL. Technical Factors Affecting the Reproducibility of Intravesical Mouse Bladder Tumor Implantation during Therapy with Bacillus Calmette-Guérin Cancer Research. 44: 3051-3054. PMID 6373001  0.32
1983 Shapiro A, Ratliff TL, Oakley DM, Catalona WJ. Reduction of Bladder Tumor Growth in Mice Treated with Intravesical Bacillus Calmette-Guérin and its Correlation with Bacillus Calmette-Guérin Viability and Natural Killer Cell Activity Cancer Research. 43: 1611-1615. PMID 6339040  0.32
1982 Ratliff TL, Thomasson DL, McCool RE, Catalona WJ. Production of macrophage activation factor by a T-cell hybridoma Cellular Immunology. 68: 311-321. PMID 7046954 DOI: 10.1016/0008-8749(82)90115-0  0.32
1982 Ratliff TL, MacDermott RP, Poepping NJ, Oakley DM, Shapiro A, Catalona WJ. Production of gamma interferon by human T and null cells and its regulation by macrophages Cellular Immunology. 74: 111-119. PMID 6819089 DOI: 10.1016/0008-8749(82)90011-9  0.32
1982 Ratliff TL, McCool RE, Catalona WJ. Optimum conditions for the reproducible measurement of concanavalin a-activated suppressor cell activity Transplantation. 33: 505-509. PMID 6211806  0.32
1982 Shapiro A, Kadmon D, Catalona WJ, Ratliff TL. Immunotherapy of superficial bladder cancer Journal of Urology. 128: 891-894. PMID 6184490  0.32
1982 Ratliff TL, Thomasson DL, McCool RE, Catalona WJ. T-cell hybridoma production of macrophage activation factor (MAF) I. Separation of MAF from interferon gamma Res Journal of the Reticuloendothelial Society. 31: 393-397. PMID 6181257  0.32
1982 Ratliff TL, Catalona WJ. Separation of macrophage activation factor and gamma interferon Federation Proceedings. 41.  0.32
1982 Ratliff TL, Kadmon D, Oakley DM. Role of NK cells in the inhibition of tumor growth by interferon Res Journal of the Reticuloendothelial Society. 32: 68-69.  0.32
1981 McCool RE, Catalona WJ, Langford MP, Ratliff TL. Induction of human gamma interferon by protein A from Staphylococcus aureus Journal of Interferon Research. 1: 473-481. PMID 6180081  0.32
1981 Catalona WJ, Ratliff TL, McCool RE. γ Interferon induced by S. aureus protein A augments natural killing and   ADCC Nature. 291: 77-79. PMID 6164924 DOI: 10.1038/291077a0  0.32
1981 Ratliff TL, McCool RE, Catalona WJ. Interferon induction and augmentation of natural-killer activity by Staphylococcus protein A Cellular Immunology. 57: 1-12. PMID 6163551 DOI: 10.1016/0008-8749(81)90114-3  0.32
1981 Ratliff TL, McCool RE, Catalona WJ. Characterization of the lymphocyte subpopulation producing interferon gamma after stimulation by protein A from staphylococcus aureus Federation Proceedings. 40.  0.32
1980 Catalona WJ, Ratliff TL, McCool RE. Characterization of cell-mediated cytolytic mechanisms against human transitional cell carcinoma line, 253J Immunology. 39: 119-125. PMID 7380462  0.32
1980 Ratliff TL, Stinson RS, Talburt DE. Effect of prostaglandin E1-induced elevation of cyclic AMP on glucose repression in the lactic streptococci Canadian Journal of Microbiology. 26: 58-63. PMID 6250686  0.32
1980 Catalona WJ, Ratliff TL, McCool RE. Concanavalin A-activated suppressor cell activity in peripheral blood lymphocytes or urologic cancer patients Journal of the National Cancer Institute. 65: 553-557. PMID 6157855  0.32
1980 Catalona WJ, Ratliff TL, McCool RE. Characterization of interferon induced in human lymphocytes by staphylococcal protein A Surgical Forum. 591-593.  0.32
1979 Catalona WJ, Ratliff TL, McCool RE. Discordance among cell-mediated cytolytic mechanisms in cancer patients: Importance of the assay system Journal of Immunology. 122: 1009-1014. PMID 448067  0.32
1979 Catalona WJ, Ratliff TL, McCool RE. Concanavalin A-inducible Suppressor Cells in Regional Lymph Nodes of Cancer Patients Cancer Research. 39: 4372-4377. PMID 159124  0.32
1978 Catalona WJ, Feldman AT, Ratliff TL, McCool RE. Suppressive effects of regional lymph node cells and extracts on antibody- dependent cellular cytotoxicity Journal of Urology. 119: 396-402. PMID 642097  0.32
1978 Catalona WJ, Ratliff TL, McCool RE. Effects of carrageenan on spontaneous and antibody-dependent cell-mediated cytotoxicity Cellular Immunology. 40: 1-15. PMID 568037 DOI: 10.1016/0008-8749(78)90310-6  0.32
1978 Catalona WJ, Ratliff TL, McCool RS. Concanavalin A-activated suppressor cells in peripheral blood and lymph nodes of urologic cancer patients Surgical Forum. 621-623. PMID 162611  0.32
Show low-probability matches.